This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Kazan University working on tuberculosis medication

June 19th, 2019 Kamill Gareev, Yury Nurmeev

The project was discussed on 14^th June with the Director of Saint-Petersburg Institute of Phthisiopulmonology Pyotr Yablonsky.

KFU and the Institute signed a cooperation agreement in March 2018. The two sides have been working on the medication since then, as Head of KFU Pharmaceutics Center Yury Shtyrlinexplained, "The substance will move to preclinical trials by the end of 2019." This stage will take about three years, and the same period will be required for clinical trials.

Dr. Yablonsky commented, "I am impressed by the equipment and the researchers that I've seen here. Firstly, I really appreciate the team's motivation—they found permanent funding and have achieved fantastic results. I am delighted that you are capable of finding financial sources despite all obstacles."

Rector Ilshat Gafurov assured the guests of KFU's eagerness to continue cooperation.

Provided by Kazan Federal University

Citation: Kazan University working on tuberculosis medication (2019, June 19) retrieved 23 April 2024 from https://sciencex.com/wire-news/322392509/kazan-university-working-on-tuberculosis-medication.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.